Novel influenza vaccine gets federal approval

01/16/2013 | HealthDay News

Protein Sciences has received FDA approval for its new flu vaccine, called Flublok, for patients aged 18 to 49. The vaccine, which is made using an insect virus expression system and genetic technology "offers the potential for faster start-up of the vaccine manufacturing process in the event of a pandemic, because it is not dependent on an egg supply or on availability of the influenza virus," according to an FDA official.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director Quality Improvement
Molina Healthcare of Texas
San Antonio, TX
Behavioral Health Medical Director
Network Health
Medford, MA
Senior Medical Director
Network Health
Medford, MA
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR